These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31173724)

  • 1. Nitric oxide-enhancing or -releasing agents as antithrombotic drugs.
    Gresele P; Momi S; Guglielmini G
    Biochem Pharmacol; 2019 Aug; 166():300-312. PubMed ID: 31173724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional regulation of vascular and platelet activity during thrombosis by nitric oxide and endothelial nitric oxide synthase.
    Moore C; Tymvios C; Emerson M
    Thromb Haemost; 2010 Aug; 104(2):342-9. PubMed ID: 20508906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The many antithrombotic actions of nitric oxide.
    Tziros C; Freedman JE
    Curr Drug Targets; 2006 Oct; 7(10):1243-51. PubMed ID: 17073585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein disulphide isomerase-mediated LA419- NO release provides additional antithrombotic effects to the blockade of the ADP receptor.
    Vilahur G; Pena E; Padró T; Badimon L
    Thromb Haemost; 2007 Apr; 97(4):650-7. PubMed ID: 17393029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
    Teng CM; Wu CC; Ko FN; Lee FY; Kuo SC
    Eur J Pharmacol; 1997 Feb; 320(2-3):161-6. PubMed ID: 9059849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
    Mousa SA; Bozarth JM; Forsythe MS; Jackson SM; Leamy A; Diemer MM; Kapil RP; Knabb RM; Mayo MC; Pierce SK
    Circulation; 1994 Jan; 89(1):3-12. PubMed ID: 8281661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis.
    Momi S; Caracchini R; Falcinelli E; Evangelista S; Gresele P
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):820-9. PubMed ID: 24558107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of nitric oxide production contributes to the antiplatelet and antithrombotic effect of new peptide pENW (pGlu-Asn-Trp).
    Liu Y; Luo W; Yang H; Fang W; Xi T; Li Y; Xiong J
    Thromb Res; 2015 Aug; 136(2):319-27. PubMed ID: 26028472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and evaluation of nitric oxide releasing derivatives of 3-n-butylphthalide as antiplatelet and antithrombotic agents.
    Wang X; Li Y; Zhao Q; Min Z; Zhang C; Lai Y; Ji H; Peng S; Zhang Y
    Org Biomol Chem; 2011 Aug; 9(16):5670-81. PubMed ID: 21706121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide insufficiency, platelet activation, and arterial thrombosis.
    Loscalzo J
    Circ Res; 2001 Apr; 88(8):756-62. PubMed ID: 11325866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Vilahur G; Segalés E; Salas E; Badimon L
    Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NCX4016: a novel antithrombotic agent.
    Gresele P; Momi S; Mezzasoma AM
    Dig Liver Dis; 2003 May; 35 Suppl 2():S20-6. PubMed ID: 12846440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antithrombotic activity of RU-891 antiaggregant agent].
    Spasov AA; Kucheriavenko AF; Tian' M; Anisimova VA
    Eksp Klin Farmakol; 2013; 76(6):25-6. PubMed ID: 24003486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of the safe margin, antithrombotic and antiproliferative actions for the treatment of restenosis: Nitric oxide donor and polymers.
    Sorragi Cde L; Shishido SM; Lemos ME; Marcondes S; Antunes E; Krieger MH
    Cell Biochem Funct; 2011 Apr; 29(3):207-14. PubMed ID: 21374644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombosis and nitric oxide donor drugs.
    Maree AO; Cox D
    Thromb Haemost; 2004 May; 91(5):848-50. PubMed ID: 15116243
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression.
    Rossiello MR; Momi S; Caracchini R; Giannini S; Guglielmini G; Monopoli A; Ongini E; Semeraro N; Colucci M; Gresele P
    J Thromb Haemost; 2005 Nov; 3(11):2554-62. PubMed ID: 16241953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets Express Activated P2Y
    Hu L; Chang L; Zhang Y; Zhai L; Zhang S; Qi Z; Yan H; Yan Y; Luo X; Zhang S; Wang Y; Kunapuli SP; Ye H; Ding Z
    Circulation; 2017 Aug; 136(9):817-833. PubMed ID: 28637879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K
    Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.